02506 訊飛醫療科技
XUNFEIHEALTH
XUNFEIHEALTH
| Register Close | 2024/12/23 IPO Closing in 3 Days |
| Listing Date | 2024/12/30 |
|
|
|
|
|
|
|
|
|
|
IPO Detail
COMPANY PROFILE
Xunfei Healthcare Technology Co., Ltd. is an AI-empowered healthcare solution provider, offering products and solutions that support a range of healthcare services, ranging from health risk warnings, early screening, auxiliary diagnosis and treatment as well as treatment effect evaluation to post-discharge management and chronic disease management.
--
The Group offers Primary Health Care (“PHC”) Services to assist PHC doctors in improving their service capabilities and enable more effective monitoring by regional healthcare administrators; Hospital Services to improve the operational efficiency of hospitals and doctors; Patient Services to enhance the convenience and quality of healthcare services received by patients, including outpatients, inpatients residing in medical institutions and discharged inpatients at home, as well as other individual customers; and Regional Healthcare Solutions to assist regional healthcare administrators in data-driven integrated management as well as efficient deployment of health insurance funds.
--
The Group ranked first in the healthcare AI industry in terms of revenue in China with a market share of 5.9% in 2023, according to Frost & Sullivan. The Group’s customers primarily including regional healthcare administrators, hospitals as well as patients and other individual customers (including those who purchase its medical devices).
BASIC INFORMATION
| Market | Hong Kong (Main Board) |
| Business Nature | Health Care |
| Major Business Area | China |
| Board Lot | 50 |
GLOBAL OFFERING
| No. of Offer Shares | 7.04M H shares |
| No. of International Offer Shares | 6.33M H shares |
| No. of HK Offer Shares | 0.70M H shares |
| Offer Price | $82.80 |
| Stock Code | 2506 |
| Sponsor(s) | Huatai Financial Holdings (Hong Kong) Limited, GF Capital (Hong Kong) Limited, CCB International Capital Limited |
| Underwriter(s) | Huatai Financial Holdings (Hong Kong) Limited, GF Securities (Hong Kong) Brokerage Limited, CCB International Capital Limited, ICBC International Securities Limited, SPDB International Capital Limited, CMBC Securities Company Limited, ABCI Securities Company Limited, China Galaxy International Securities (Hong Kong) Co., Limited, TradeGo Markets Limited, Advent Securities (Hong Kong) Limited |
TIME TABLE
| Application Period | Dec 18 (Wed) - noon, Dec 23 (Mon) |
| Price Determination Date | -- |
| Result Announcement Date | On or before Dec 27 (Fri) |
| Result Announcement Date | On or before Dec 27 (Fri) |
| Result Announcement Date | On or before Dec 30 (Mon) |
| Dealings in Shares commence on | Dec 30, 2024. (Mon) |
Reallocation of Shares Offered
| Times of HK Offer Shares Subscription | 15X - 50X | 50X - 100X | Over 100X |
| % of total shares reallocated to HK Offer | 30% | 40% | 50% |
Sales Statistics (HKD)
| Offer Price | $82.80 |
| Capitalization (H Shares) | 6.40B |
| NAV / share ($) | $6.87 (Unaudited pro forma adj NAV / share) |
Use Of Proceeds
| Assuming the offer price being at HKD 82.8, the net proceeds raised would be HKD 507.10M, of which |
| 32.4% : Invest in research and development including upgrading Xunfei Spark Medical Model, optimizing algorithms and reinforcing core technologies such as machine learning |
| 26.6% : Upgrading existing products and develop new products |
| 24.7% : Reinforce commercialization capabilities and expand service network |
| 6.4% : Acquire companies that may generate synergies with existing capacities, such as medical device manufactures |
| 10% : Ｗorking capital |
Related Document
| Prospectus |  Chinese Version | English Version |
| Remark： | The above information is referenced from the prospectus. |
| All data is calculated from the non- exercise rights(if applicable). |
Name︰
--
--
--
Subscription --
Result Announcement --
Listing --Offer Price︰--
| Currency | : |
| Listing Price | : |
| Board Lot | : |
| Admission Fee* |
: |
| Subscribing Lot | : |
| Subscribing Fee | : |
| Subscribing Amount | : |
*Admission fees include brokerage of 1%, SFC transaction levy of 0.0027%, Stock Exchange trading fee of 0.005% and FRC transaction levy of 0.00015% (i.e. 1.0077% in total).